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Outer membrane protein A (OmpA) is a class of proteins
highly conserved among the Enterobacteriaceae family and
throughout evolution. Klebsiella pneumoniae is a capsulated
Gram-negative pathogen. It is an important cause of communi-
ty-acquired and nosocomial pneumonia. Evidence indicates
that K. pneumoniae infections are characterized by a lack of an
early inflammatory response. Data from our laboratory indicate
that K. pneumoniae CPS helps to suppress the host inflamma-
tory response. However, it is unknown whether K. pneumoniae
employs additional factors to modulate host inflammatory
responses. Here, we report thatK. pneumoniaeOmpA is impor-
tant for immune evasion in vitro and in vivo. Infection of A549
and normal human bronchial cells with 52OmpA2, an ompA
mutant, increased the levels of IL-8. 52145-wcaK2ompA,
which does not express CPS and ompA, induced the highest lev-
els of IL-8. Both mutants could be complemented. In vivo,
52OmpA2 inducedhigher levels of tnf, kc, and il6 than thewild
type. ompAmutants activated NF-B, and the phosphorylation
of p38, p44/42, and JNK MAPKs and IL-8 induction was via
NF-B-dependent and p38- and p44/42-dependent pathways.
52OmpA2 engaged TLR2 and -4 to activate NF-B, whereas
52145-wcaK2ompA activated not only TLR2 and TLR4 but
also NOD1. Finally, we demonstrate that the ompA mutant is
attenuated in the pneumonia mouse model. The results of this
study indicate that K. pneumoniaeOmpA contributes to atten-
uate airway cell responses. Thismay facilitate pathogen survival
in the hostile environment of the lung.
The OM3 of Gram-negative bacteria is composed of phos-
pholipids, LPS, and outer membrane proteins. These proteins
are important for membrane integrity and transport of mole-
cules across the membrane (for a review, see Ref. 1). OmpA
(outer membrane protein A) is one of the best characterized
OM proteins. Its crystal structure has been determined (at a
resolution of 1. 65 Å), and it consists of an eight-stranded all-
next-neighbor antiparallel -barrel with short turns at the
periplasmic barrel (2). Anumber of studies have highlighted the
role ofOmpA in pathogenesis.Escherichia coliOmpAmediates
adhesion and/or invasion to epithelial cells and macrophages
(3, 4). It also mediates serum resistance and may protect bacte-
ria against the bactericidal action of lung collectins SP-D and
SP-A (5, 6). However, OmpA is also targeted by the innate
immune system. Neutrophil elastase, a protein included in the
array of oxygen-independent weapons of the innate immune
system, degrades OmpA, resulting in cell death (7). The acute-
phase protein serum amyloid protein A binds to OmpA, and
this is associated with an increased uptake of bacteria by neu-
trophils and macrophages (8, 9).
Airway epithelial cells play a pivotal role in lung defense
against infections by detecting pathogens, thereby leading to
the activation of signaling pathways resulting in the production
of antimicrobial molecules, the expression of co-stimulatory
molecules, and the release of cytokines and chemokines (10,
11). In particular, IL-8 is a major secreted product of infected
cells independent of the infecting microorganism (12, 13). This
chemokine is a potent chemoattractant for polymorphonuclear
cells into the infected tissue (12, 13). To launch these responses,
airway epithelial cells recognize conservedmolecules expressed
by pathogens, the so-called PAMPs, through a set of germ line-
encoded receptors referred to as PRRs (14, 15). The best char-
acterized PRRs belong to the families of Toll-like receptors
(TLRs) and nucleotide binding and oligomerization domain-
like receptors (NLRs) (16–18). Among TLRs, most of the stud-
ies focus on TLR4, mainly involved in the detection of LPS, and
on TLR2, which responds to a variety of Gram-positive PAMPs
(10, 14, 15). AmongNLRs,NOD1has received increasing atten-
tion. NOD1 is located intracellularly, and evidence indicates
that it recognizes a peptidoglycan motif from Gram-negative
bacteria (16, 17).
Klebsiella pneumoniae is a capsulated Gram-negative patho-
gen that causes a wide range of infections, from urinary tract
infections to pneumonia, the latter being particularly devastat-
ing among immunocompromised patients with mortality rates
between 25 and 60% (19). The best characterized virulence fac-
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tor of this species is CPS, which is responsible for protection
against complement and antimicrobial peptide-mediated kill-
ing (20–22). In addition, isogenic CPS mutant strains are avir-
ulent, being unable to cause pneumonia and urinary tract infec-
tions (23–25).
A wealth of evidence indicates that activation of inflamma-
tory responses is essential to clearKlebsiella infections (26–28)
and that TLRs seem to play a major role in detecting K. pneu-
moniae (29, 30). Conversely, this suggests that K. pneumoniae
may somehow try to counteract the induction of these host
defense responses. Indeed, we and others (31, 32) have shown
that in sharp contrast to wild-type strains, avirulent CPS
mutants activate an inflammatory program through TLR-de-
pendent pathways. In fact, it has been postulated that CPS helps
to suppress the host inflammatory response, thereby allowing
the bacteria to replicate in a more permissive niche. Whether
K. pneumoniae employs additional factors to modulate host
inflammatory responses is still unknown. In this context, sev-
eral studies have shown that recombinant purified OmpA from
K. pneumoniae induces the expression of inflammatory mole-
cules in a TLR2-dependent manner in various cell types (33–
35). Hence, it has been postulated that detection of K. pneu-
moniae OmpA may contribute to the activation of host
responses leading to the clearance ofK. pneumoniae (36). How-
ever, there might be differences between the cellular recogni-
tion of recombinant purified OmpA and OmpA expressed in
the complex lipid environment of the bacterial OM, and hence
the cellular responses could be different.
The purpose of this studywas to analyzewhetherOmpAmay
contribute to the activation of inflammatory responses when
expressed in the bacterial OM. To this end, we compared the
host responses to wild-type K. pneumoniae and an isogenic
ompAmutant.We report that K. pneumoniaeOmpA is impor-
tant for immune evasion of K. pneumoniae in vitro and in vivo.
Mechanistically, we demonstrate that the ompA mutant
induces the secretion of inflammatory mediators via activation
of NF-B and MAPKs p38 and p44/42. In addition, we show
that ompA mutant induction of inflammatory responses is
dependent on TLR activation. Finally, we demonstrate that the
K. pneumoniae ompAmutant is attenuated in amousemodel of
pneumonia.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Growth Conditions, and Reagents—
K. pneumoniae 52145 is a clinical isolate (serotype O1:K2)
described previously (24, 37). The isogenic mutants 52OmpA2,
which does not express ompA; 52145-wcaK2, which does not
express CPS; and 52145-wcaK2ompA, which does not express
CPS and ompA, have been described previously (38, 39). Anal-
ysis of OMproteins from these strains as well as the description
of the complementing strains have been reported previously
(39). Bacteria were grown in Luria-Bertani medium at 37 °C.
When appropriate, antibiotics were added to the growth
medium at the following concentrations: rifampicin (50
g/ml), kanamycin (50 g/ml), and chloramphenicol (25
g/ml). Caffeic acid phenethyl ester (CAPE), an NF-B inhibi-
tor, and SB203580, a p38 MAPK inhibitor, were purchased
from Sigma, whereas U0126, a p44/42 MAPK inhibitor, and
SP600125, a JNK inhibitor, were purchased from Calbiochem.
CPS Purification and Quantification—Cell-associated CPSs
fromK. pneumoniae strains, grown in 5ml of LB,were obtained
using the hot phenol-water method exactly as described previ-
ously (20). CPS was quantified by determining the concentra-
tion of uronic acid in the samples, using a modified carbazole
assay (40), exactly as described by Rahn and Whitfield (41).
Cell Culture and Infection—Monolayers of A549 (ATCC
CCL185) andNHBE (Lonza) cells were grown as described pre-
viously (32). For infections, A549 cells were seeded to 90% con-
fluence (3 105 cells/well) in 24-well tissue culture plates. Cells
were serum-starved for 16 h before infection. For NHBE cells,
cells were seeded to 80% confluence (2 105 cells/well) in col-
lagen-coated 24-well tissue culture plates using 1 ml of bron-
chial epithelial cell growth medium (Lonza) per well. Bacteria
were prepared as described (32, 42), and infections were per-
formed using a multiplicity of infection of 100 bacteria/cell,
unless indicated otherwise. To synchronize infection, plates
were centrifuged at 200  g for 5 min. For incubation times
longer than 120 min, bacteria were killed by the addition of
gentamicin (100 g/ml), which was not removed until the end
of the experiment. For experiments reported in Fig. 2, infec-
tions were performed for 3 h. Cell viability was assessed by
trypan blue dye exclusion, and it was 95% even after 9 h of
infection.
Adhesion and Internalization Assays—To determine the
adhesion of Klebsiella strains to A549 cells, after 2 h of infec-
tion, monolayers were washed five times with PBS, and cells
were lysed with 300 l of 0.5% saponin-PBS for 5 min at room
temperature, and serial dilutions were plated on LB agar plates
for viable counts of bacteria. The results are expressed as log
cfu/well. For invasion assays, cells were infected for 2 h and
washed three times with PBS and then incubated for an addi-
tional 2 h with fresh medium plus gentamicin (100 g/ml) to
kill extracellular bacteria. This treatment was long enough to
kill all extracellular bacteria. Epithelial monolayers were
washed three timeswith PBS and lysed as described before. The
results are expressed as log cfu/well. Experiments were carried
out in triplicate on at least two independent occasions.
IL-8 StimulationAssay—Epithelialmonolayerswere infected
for different time periods. Supernatantswere removed from the
wells, cell debris was removed by centrifugation, and samples
were frozen at80 °C. IL-8 in the supernatantswas determined
by a commercial ELISA (BenderMedSystems) with a sensitivity
of2 pg/ml. Experimentswere run in duplicate and repeated at
least three times.
Transfections and Luciferase Assays—A549 cells were seeded
into 24-well tissue culture plates to obtain a 40–60% conflu-
ence 24 h later. Cells were washed twice with PBS before trans-
fection. Transfection experiments were carried out in 500 l of
Opti-MEM reduced serum medium (Invitrogen) using Lipo-
fectamineTM 2000 transfection reagent following the manufac-
turer’s recommendations (Invitrogen).
For luciferase experiments, the PathDetect NF-B cis-re-
porting plasmid (250 ng; Stratagene) was co-transfected with
the pRL-TK Renilla luciferase control reporter vector (20 ng;
Promega). For luciferase assays, cells were lysed with passive
K. pneumoniae OmpA Prevents Inflammation
MARCH 25, 2011•VOLUME 286•NUMBER 12 JOURNAL OF BIOLOGICAL CHEMISTRY 9957
 at U
N
IV
 PU
BLICA
 D
E N
A
V
A
RRA
 on D
ecem
ber 21, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
lysis buffer (Promega). Luciferase activity was assayed using the
dual luciferase assay kit according to the manufacturer’s
instructions (Promega). Firefly luciferase values were normal-
ized to Renilla control values. Results were plotted as relative
luciferase activity compared with activity measured in non-
stimulated control cells. The luciferase assay was carried out in
triplicate on at least three independent occasions.
Small Interfering RNA (siRNA)—Interference RNA for TLR4
(catalogue number HSS110818), TLR2 (catalogue number
HSS110813), and CARD4/NOD1 (catalogue number
HSS115906) were purchased from Invitrogen. StealthTMRNAi
negative control low GC was used as control interference RNA
for TLR2 and TLR4, whereas StealthTM RNAi negative control
medium GC was used as control interference RNA for NOD1.
RNA-mediated interference for down-regulating MyD88 was
done by the transfection of MyD88 siRNA (5-AACTGGAA-
CAGACAAACTATC-3) purchased from Qiagen. The AllStars
negative control siRNA (Qiagen) was used as non-silencing con-
trol interference RNA. In all cases, 20 nM siRNA/well was used for
transfection using LipofectamineTM 2000 transfection reagent
and following the manufacturer’s recommendations (Invitrogen).
Cells were infected 48 h post-transfection as described above.
Real-time Quantitative PCR (RT-qPCR)—Quantification of
mRNA levels was conducted by RT-qPCR. RNA was purified
using a Nucleospin RNAII kit (Macherey-Nagel) exactly as rec-
ommended by themanufacturer. cDNAwas obtained by retro-
transcription of 1.5–2g of total RNA using a commercial RT2
first strand kit as recommended by the manufacturer (SABio-
science). The reaction included one step to eliminate traces of
genomic DNA. Real-time PCR (RT-PCR) analyses were per-
formed with a Smart Cycler real-time PCR instrument (Ceph-
eid, Sunnyvale, CA). To amplify human TLR2, TLR4, MyD88,
and NOD1, 500 ng of cDNA were used as a template in a 25-l
reaction containing 1 QuantiTect SYBR Green PCR mix
(Qiagen) and QuantiTect primer assays (Qiagen; catalogue
numbersQT00236131 (TLR2) andQT00035238 (TLR4)) or the
intron-spanning primers: 5-GGCATCACCACACTTGAT-
GAC-3 (sense) and 5-ATAGACCAGACACAGGTGCCAG-3
(antisense) for MyD88 and 5-TCAAGTTGGGGATGAAG-
GAG-3 (sense) and 5-GCCAAACTCTCTGCCACTTC-3
(antisense) for NOD1. As an internal control, we amplified the
human housekeeping gene GAPDH using 50 ng of cDNA and
the following intron spanning primers: 5-GAAGGTGAA-
GGTCGGAGTC-3 (sense); 5-GAAGATGGTGATGGGAT-
TTC-3 (antisense). The thermocycling protocol was as fol-
lows: 95 °C for 15 min for hot start polymerase activation,
followed by 45 cycles of denaturation at 95 °C for 30 s, annealing
at 60 °C for TLRs,MyD88, and NOD1 or 54 °C for GADPH for
30 s; and extension at 72 °C for 30 s. The SYBR Green dye was
measured at 521 nm during the annealing phase. The threshold
cycle (Ct) value reflects the cycle number at which the fluores-
cence generated within a reaction crosses a given threshold.
TheCt value assigned to eachwell thus reflects the point during
the reaction at which a sufficient number of amplicons have
been accumulated. The relative mRNA amount in each sample
was calculated based on its Ct in comparison with the Ct of
GAPDH. Specificity of the PCR products was determined by
melting curve analysis, and amplification products were
resolved on a 1.5% agarose gel to confirm the correct size of the
amplicons (92, 102, 185, 201, and 226 bp for TLR2, TLR4,
MyD88, NOD1, and GAPDH, respectively).
Immunoblotting—Proteins from lysed cells were separated
by 10% SDS-PAGE, electrotransferred to nitrocellulose mem-
brane, and blocked with 4% skimmed milk in PBS. Immuno-
stainings for MKP-1, CYLD, and IB were performed using
polyclonal rabbit antibodies anti-MKP-1 (1:1,000; Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA)), anti-IB (1:1,000; Cell
Signaling), and anti-CYLD (1:1,000) (Imgenex Corp.) Immu-
nostainings to assess phosphorylation of NF-B p65, p38, p44/
42, and JNK MAPKs were performed with polyclonal rabbit
anti-phospho-p65, anti-phospho-p38, anti-phospho-p44/42,
and anti-phospho-JNK antibodies, respectively (all used at
1:1,000; Cell Signaling). Immunoreactive bands were visualized
by incubation with swine anti-rabbit immunoglobulins conju-
gated to horseradish peroxidase (Dako P0217) using the Super-
Signal West-dura system (Pierce). Blots were reprobed with
polyclonal anti-human tubulin antibody (1:3,000; Santa Cruz
Biotechnology, Inc.) to control that equal amounts of proteins
were loaded in each lane.
NOD1 NF-B Activation Assay—HEK293T, seeded in
24-well plates, were transfected overnight with pCI-Nod1 (0.3
ng; kindly donated byT. Kufer), PathDetectNF-B cis-report-
ing plasmid (75 ng), pRL-TKRenilla luciferase (7.5 ng), and 120
ng of pcDNA3 (120 ng) to balance the DNA concentration.
Cells were transfected using calcium chloride. 24 h post-trans-
fection, cells were washed once with PBS and infected for 2 h,
washed once with PBS, and then incubated for an additional 6 h
with fresh medium plus gentamicin (100 g/ml) before per-
forming luciferase measurements.
Intranasal Infection Model—5–7-week-old female C57BL/
6JOlaHsd mice (Harlan) were anesthetized by intraperitoneal
injection with a mixture containing ketamine (50 mg/kg) and
xylazine (5 mg/kg). Overnight bacterial cultures were centri-
fuged (2,500  g, 20 min, 22 °C), resuspended in PBS, and
adjusted to 5  106 cfu/ml for analysis of cytokine expression
and to 5 104 cfu/ml for determination of bacterial loads. 20l
of the bacterial suspension were inoculated intranasally in four
5-l aliquots. Non-infected mice were inoculated intranasally
with 20 l of PBS in four 5-l aliquots. To facilitate consistent
inoculations, mice were held vertically during inoculation and
placed on a 45° incline while recovering from anesthesia. At the
indicated times after infection, mice were euthanized by cervi-
cal dislocation, and lungs were either rapidly dissected for bac-
terial load determination or immediate frozen in liquid nitro-
gen and stored at80 °C until purification of RNA was carried
out. To this end, lungswere quicklyweighted and homogenized
with 1 ml of TRI reagent (Ambion) using an Ultra-Turrax TIO
basic (IKA) on ice. Total RNAwas purified first using a standard
chloroform/isopropyl alcohol protocol, and the obtained
RNA was further purified using a Nucleospin RNAII kit
(Macherey-Nagel) exactly as recommended by the manufac-
turer. RNA integrity was verified using a formaldehyde-agarose
gel, quantified spectrophotometrically with a NanoDrop spec-
trophotometer, and stored at 80 °C. mRNA expression was
measured by RT-qPCR analysis as described above. The follow-
ing intron-spanning primers were used: 5-CCACATC-
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TCCCTCCAGAAAA-3 (sense) and 5-AGGGTCTGGGCC-
ATAGAACT-3 (antisense) for tnf-; 5-CCGGAGAGGAGA-
CTTCACAG-3 (sense) and 5-CAGAATTGCCATTGCAC-
AAC-3 (antisense) for il-6; and 5-GACAGACTGCTCTG-
ATGGCA-3 (sense) and 5-TGCACTTCTTTTCGCAC-
AAC-3 (antisense) for kc. As internal controls, we amplified
the mouse housekeeping actin and gapdh (5-TGTTAC-
CAACTGGGACGACA-3 (sense) and 5-CTGGGTCATCT-
TTTCACGGT-3 (antisense) for actin and 5-CCCACTAACA-
TCAAATGGGG-3 (sense) and 5-CCTTCCACAATGCCAA-
AGTT-3 (antisense) for gapdh. The sizes of the amplicons are
259, 134, 292, 139, and 274 bp for tnf-, il-6, kc, actin, and
gapdh, respectively.
Dissected lungs from those animals infected to determine
bacterial loads were homogenized in 500 l of PBS using an
Ultra-Turrax TIO basic disperser (IKA) on ice. Bacteria from
the homogenates and serial dilutions thereof were recovered in
LB agar plates containing rifampicin for the wild-type strain or
rifampicin plus kanamicin for the ompA mutant. Results were
reported as log cfu/g of tissue. Mice were treated in accordance
with the European Convention for the Protection of Vertebrate
Animals used for Experimental and other Scientific Purposes
(Directive 86/609/EEC) and in agreement with the Bioethical
Committee of the University of the Balearic Islands (Spain).
Statistical Methods—Statistical analyses were performed
using one-way analysis of variance (ANOVA) with Bonferroni
contrasts or the one-tailed t test or, when the requirements
were not met, by the Mann-Whitney U test. p 0.05 was con-
sidered statistically significant. The analyses were performed
using Prism4 for PC (GraphPad Software).
RESULTS
Infection of Airway Epithelial Cells by K. pneumoniae ompA
Mutant Induces the Secretion of IL-8—Previous data (32), fur-
ther confirmed here, had shown that wild-type K. pneumoniae
strain 52145 (hereafter referred to as Kp52145) does not induce
the secretion of IL-8 by A549 cells (Fig. 1A). We asked whether
infection with strain 52OmpA2, an isogenic ompA mutant,
would induce the secretion of IL-8. Time course experiments
showed a correlation between the duration of the infectionwith
52OmpA2 and the levels of IL-8 secreted by A549 cells, the
levels of IL-8 being higher at 8 than at 4 h postinfection (Fig.
1A). Moreover, at 6 and 8 h postinfection, 52OmpA2-infected
cells secreted levels of IL-8 significantly higher than those of
Kp52145-infected cells, which were similar to those of non-
infected cells (Fig. 1A) (p 0.05; one-tailed Student’s t test).
Evidence indicates that K. pneumoniae CPS mutants induce
the secretion of IL-8 by airway epithelial cells (32). Therefore,
the induction of IL-8 by 52OmpA2 could be due to a reduction
in the amount of CPS expressed by this mutant. However,
Kp52145 and 52OmpA2 expressed similar amounts of cell-
bound CPS (360  15 g/106 cells and 339  23 g/106 cells,
respectively; p  0.05; one-tailed Student’s t test). We tested
whether the absence of OmpA further increases the levels of
IL-8 induced by 52145-wcaK2, an isogenic CPS mutant from
Kp52145. Indeed, at 8 h postinfection, 52145-wcaK2ompA-
infected cells secreted higher levels of IL-8 than 52145-wcaK2-
or 52OmpA2-infected cells (Fig. 1B). IL-8 levels induced
by 52OmpA2Com- and 52145-wcaK2ompACom-comple-
mented strains of 52OmpA2 and 52145-wcaK2, respectively,
were not significantly different from those triggered by
Kp52145 and 52145-wcaK2, hence indicating that the absence
of OmpA is responsible for the induction of IL-8 secretion by
OmpA mutants. For the sake of comparison, IL-8 levels
induced by 52OmpA2 and 52145-wcaK2ompA were com-
pared in a time course experiment (Fig. 1C). At all time points,
52145-wcaK2ompA-infected cells secreted higher levels of
IL-8 than 52OmpA2-infected ones. ompA mutants also
induced higher levels of IL-8 than parental strains in normal
human bronchial cells (Fig. 1D). At 8 h postinfection, ompA
mutants induced higher levels of IL-8 than the parental strains,
52145-wcaK2ompA being the strain inducing the highest lev-
els. Both mutants were complemented (Fig. 1D). Collectively,
these data show that CPS and OmpA are bacterial factors
required to reduce the secretion of IL-8 by airway epithelial
cells upon K. pneumoniae infection.
Control experiments revealed that the adhesion and inter-
nalization to cells were not significantly different between each
ompA mutant and its corresponding parental strain (Fig. 1E).
As reported previously (43, 44), strains lacking CPS adhered
and were internalized in higher numbers than CPS-expressing
strains (for each comparison between CPS-expressing and
CPS-negative strains, p  0.05 (one-tailed Student’s t test)
(Fig. 1E).
ompAMutant Attenuates IL-1-induced IL-8 Secretion—Re-
cently, we have shown that Kp52145 attenuates proinflamma-
tory mediator-induced IL-8 secretion (45). This process
requires bacteria-cell contact, and removal of bacteria by wash-
ing followed by 1-h gentamicin treatment rendered cells
responsive to agonist-induced IL-8 secretion (45). To exert this
anti-inflammatory effect, Kp52145 up-regulates the expression
of the deubiquitinase CYLD and the phosphatase MKP-1
(DUSP1) in a NOD1-dependent manner (45). To explore
whether OmpA could account for the Kp52145 anti-inflamma-
tory effect, we determined the effect of 52OmpA2 on IL-1-
induced IL-8 secretion by A549 cells using the assay that we
have described (45). Similarly toKp52145, 52OmpA2did atten-
uate IL-1-induced IL-8 secretion (Fig. 2A). Furthermore,
Western blot analysis revealed that 52OmpA2 induced the
expression of CYLD and MKP-1 (Fig. 2B). This was dependent
onNOD1 because 52OmpA2 did not increase the expression of
CYLD and MKP-1 in NOD1 knockdown cells (Fig. 2C).
K. pneumoniae ompAMutant Induces Higher Levels of Cyto-
kines than Wild-type Strain in Vivo—We investigated whether
52OmpA2 induces higher levels of cytokines than Kp52145 in
the lungs of infected mice. Mice were infected intranasally and
euthanized at different time points. Whole lungs were dis-
sected, and the expressions of kc, tnf, and il6weremeasured by
RT-qPCR at 6, 12, and 24 h postinfection (Fig. 3). Levels of kc,
tnf, and il6were higher in lungs of infectedmice than in lungs
of non-infected animals (p  0.05 for all comparisons versus
non-infected mice (one-tailed Student’s t test)) (Fig. 3). How-
ever, levels of kc were higher in lungs of mice infected with
52OmpA2 than in those infected with Kp52145 at all time
points analyzed. 52OmpA2Com induced similar levels of kc
than Kp52145. Only at 12 h postinfection, levels of tnf were
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FIGURE 1. K. pneumoniae ompAmutants induce higher levels of IL-8 than wild-type strains by airway epithelial cells. A, ELISA of IL-8 released by A549
cells left untreated (CON) or infected for different time pointswith Kp52145 (gray bars) and 52OmpA2 (black bars) (n 3). B, ELISA of IL-8 released by A549 cells
left untreated (CON) or infected for 8 h with different K. pneumoniae strains (n 3). C, ELISA of IL-8 released by A549 cells left untreated (CON) or infected for
different time points with 52OmpA2 (gray bars) and 52145-wcaK2ompA (black bars) (n 3). D, ELISA of IL-8 released by NHBE cells left untreated (CON) or
infected for 8 h with different K. pneumoniae strains (n  3). E, adhesion (left) and internalization (right) of Klebsiella strains to A549 cells (n  3). Gray bars,
CPS-expressing strains; black bars, CPS negative strains. The data (A–E) aremeans and S.E. (error bars). A–D, *, p 0.05 (for the indicated comparisons; one-way
ANOVA). E, *, p 0.05 (results are significantly different from the results for Kp52145; one-tailed t test).
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significantly different between Kp52145- and 52OmpA2-in-
fected mice. At 12 and 24 h postinfection, levels of il6 were
higher in lungs of mice infected with 52OmpA2 than in those
infected with Kp52145. Levels of il6 were not significantly dif-
ferent between mice infected with Kp52145 and animals
infected with 52OmpA2Com at all time points. In summary,
these data show that OmpA plays a role in vivo contributing to
reduce host inflammatory responses.
Activation of NF-B Is Required for K. pneumoniae ompA
Mutant-induced IL-8 Expression—We next aimed to identify
the signaling pathways activated by the ompAmutant to induce
an inflammatory response. Several studies show that NF-B
participates in the inducible expression of genes involved in the
inflammatory response, including IL-8 (46). Therefore, we ana-
lyzed the effect of 52OmpA2 on the NF-B activation pathway
by studying the activation of a reporter construct controlled by
syntheticNF-B response elements. A549 cellswere transiently
transfected with a NF-B-dependent luciferase reporter fol-
lowed by infection, and infection-induced NF-B activation
wasmeasured as relative luciferase activity (Fig. 4A). In contrast
to Kp52145, 52OmpA2 induced the activation of the reporter
construct. Complemented strain 52OmpA2Com induced a
NF-B-dependent luciferase activity similar to Kp52145-in-
fected cells. Supporting previous findings (22, 32), 52145-
wcaK2 induced the reporter construct, which was further
induced by 52145-wcaK2ompA (Fig. 4A). Complementation
of the mutant, strain 52145-wcaK2ompACom, restored
NF-B-dependent luciferase activity to 52145-wcaK2-in-
duced levels (Fig. 4A).
Upon cellular stimulation, in the canonical pathway of
NF-B activation, IB, which is normally present in the cyto-
sol complexed to NF-B dimers preventing nuclear transloca-
tion, becomes phosphorylated, leading to its ubiquitination and
subsequent degradation by the proteosome, thereby allowing
nuclear translocation of NF-B, a process linked to phosphor-
ylation of the p65 subunit (47). We analyzed the levels of phos-
phorylated p65 byWestern blot. At 60min postinfection, phos-
phorylated p65was detected in extracts from infected cells (Fig.
4B). However, these levels were higher in 52OmpA2-infected
cells than in Kp52145-infected ones. Complementation of the
mutant restored phoshorylated p65 levels to those of Kp52145-
infected cells (Fig. 4B). IB levels in cytoplasmic extracts were
analyzed by immunoblot. IB degradation was apparent in
extracts from cells infected with 52OmpA2 already 15 min
postinfection, and it was still apparent at 90 min postinfection.
In contrast, IB degradation was only detected at 15 and 30
min postinfection in extracts from Kp52145-infected cells, and
at later time points, IB levels were similar to those of non-
infected cells. For the sake of comparison, the levels of IB in
cell extracts infected with the CPS mutants were also analyzed.
In 52145-wcaK2ompA-infected cells, IB degradation was
clearly detected at 15 min postinfection, and it was almost total
at 90 min postinfection. IB degradation in 52145-wcaK2-
infected cells was apparent at 30min postinfection andwas still
detected at 90 min postinfection.
To determine the contribution of NF-B activation to ompA
mutant-induced IL-8 expression, we asked whether CAPE, a
chemical inhibitor used to block the NF-B signaling pathway
(48), alters infection-induced IL-8 expression. As shown in Fig.
4D, CAPE (15 g/ml) reduced 52OmpA2- and 52145-
FIGURE 2. K. pneumoniae ompA attenuates IL-1-induced IL-8 expres-
sion. A, ELISA of IL-8 released by A549 left untreated (CON) or infected for 1 h
with Kp52145 or 52OmpA2 and then stimulated with IL-1 (50 ng/ml) for 2 h
(n3). *,p0.05 (for the indicated comparisons; one-wayANOVA).B, immu-
noblot analysis ofCYLD,MKP-1, and tubulin levels inA549cells left uninfected
(CON) or infected with Kp52145 or 52OmpA2 for 3 h. Data are representative
of three independent experiments. C, immunoblot analysis of CYLD, MKP-1,
and tubulin levels inA549 cells transfectedwitheither control orNOD1siRNA,
which were left uninfected (CON) or infected with Kp52145 or 52OmpA2 for
3 h. Data are representative of three independent experiments.
FIGURE3.Proinflammatory cytokineexpressions inmice lungsafterK. pneumoniae infections.Micewerenon-infected (white bars,n5)or infectedwith
wild-type K. pneumoniae 52145 (black bars, n  15), 52OmpA2 (black bars; n  15), or 52OmpA2Com (gray bars; n  15). kc (A), tnf (B), and il6 (C) mRNA
expressions in whole lungs at the indicated time points postinfection were assessed by RT-qPCR (5mice/time point). Bars, mean S.E. (error bars). *, p 0.05
(for the indicated comparisons; one-way ANOVA).
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wcaK2ompA-triggered IL-8 levels. Control experiments
showed that addition of DMSO (the solvent used for CAPE) to
either 52OmpA2- or 52145-wcaK2ompA-infected cells did
not affect IL-8 levels (in the absence of DMSO, 457  28 and
721 70 pg/ml, respectively; in the presence of DMSO, 490
35 and 747  64 pg/ml, respectively). CAPE-treated cells (15
g/ml) expressed levels of IL-8 (110  85 pg/ml) similar to
those of non-treated cells (97 50 pg/ml).
Collectively, these data demonstrated that IB-dependent
activation of NF-B is required for ompA induction of IL-8
expression inA549 cells.Moreover, CPS andOmpA contribute
to limit the activation of the canonical NF-B signaling
pathway.
Activation of MAPKs Is Required for K. pneumoniae ompA
Mutant-induced IL-8 Expression—In addition to the NF-B
signaling cascade, many cellular stimuli also activate MAPK
pathways (49). The activation of the three MAPKs p38, JNK,
and p44/42 occurs through phosphorylation of serine and thre-
onine residues. We sought to determine the phosphorylation
levels of the three MAPKs in 52OmpA2-A549-infected cells.
Western blot analysis shown in Fig. 5A revealed that infection
with 52OmpA2 triggered the phosphorylation of the three
MAPKs. Phosphorylation of the three MAPKs occurred at ear-
lier time points in 52OmpA2-infected cells than in Kp52145-
infected ones.MAPKs phosphorylation levels were also studied
in 52145-wcaK2ompA- and 52145-wcaK2-infected cells. In
52145-wcaK2ompA-infected cells, phosphorylation of p38
was apparent at 30min postinfection andmaximum levels were
observed at 120 min postinfection, whereas in 52145-wcaK2-
infected cells, p38 phosphorylation was apparent at 60 min
postinfection, and maximum levels were observed at 120 min
postinfection. No clear differences in the phosphorylation of
p44/42 were observed between 52145-wcaK2ompA- and
52145-wcaK2-infected cells. In 52145-wcaK2ompA-infected
cells, maximum levels of phosphorylated JNK were observed at
30 min postinfection, whereas in 52145-wcaK2-infected cells,
phosphorylation of JNK was apparent at 30 min postinfection,
and maximum levels were observed at 120 postinfection.
To explore whether the activation of MAPKs is involved in
52OmpA2-induced IL-8 expression, infections were carried
out in the presence of chemical inhibitors for each MAPK. Fig.
5B shows that SB203580, a specific inhibitor of p38 MAPK,
reduced 52OmpA2-induced IL-8 expression. The p44/42
inhibitor, U0126, also reduced 52OmpA2-dependent IL-8
expression but only at the highest dose tested (Fig. 5C). Finally,
SP600125, a JNK inhibitor, did not alter 52OmpA2-induced
IL-8 expression (Fig. 5B).We sought to determinewhether acti-
vated MAPKs are involved in 52145-wcaK2ompA-triggered
IL-8 levels. SB203580 and U0126 at the highest dose tested
also reduced 52145-wcaK2ompA-induced IL-8 expression,
FIGURE 4. Activation of NF-B is required for K. pneumoniae ompAmutant-induced IL-8 expression. A, activation of a NF-B luciferase reporter plasmid
in A549 cells left untreated (CON) or infected for 8 h with K. pneumoniae strains. Activity is normalized by correction of Renilla expression and is presented
relative to the cells untreated (n 3). *, p 0.05 (for the indicated comparisons; one-way ANOVA). B, immunoblot analysis showing phospho-p65 and tubulin
levels in lysates ofA549 infectedwithK. pneumoniae strains for 90min IL-1 (20ng/ml for 30min)wasusedas apositive control forNF-Bactivation. The results
are representative of three independent experiments.C, immunoblots of IB and tubulin levels in lysates of A549 cells left untreated (CON; time 0) or infected
for different time periods with K. pneumoniae strains. Data are representative of three independent experiments. D, ELISA of IL-8 released by A549 cells left
untreated (CON; white bar) or infected for 6 h with 52OmpA2 (gray bars) or 52145-wcaK2ompA (black bars) in the absence or presence of different concen-
trations of CAPE, an inhibitor of NF-B, which was added 1 h before infecting the cells and kept until the end of the experiment (n 3). The data (A and C) are
means and S.E. (error bars).
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whereas SP600125 did not reduce IL-8 levels (Fig. 5B).
SB203580-, U0126-, and SP600125-treated cells secreted simi-
lar amounts of IL-8 (120  95, 95  67, and 135  87 pg/ml,
respectively) as non-treated cells (130  75 pg/ml). Taken
together, these findings indicate that the activation of MAPKs
p38 and p44/42 is involved in K. pneumoniae ompA mutant-
induced expression of IL-8 in A549 cells.
Dissection of Host Cell Receptors Required for Activation of
Inflammatory Responses by K. pneumoniae ompA Mutant
Strains—PRRs have a central role in pathogen recognition by
airway epithelial cells leading to the activation of NF-B- and
MAPK-dependent signaling pathways; we therefore investi-
gated the involvement of PRRs in recognition ofK. pneumoniae
ompA mutants by using as cellular read-outs the activation of
NF-B and the secretion of IL-8. Almost all TLRs activate cel-
lular signaling pathways through TIR domain-mediated inter-
actions with the adaptor molecule MyD88 (50). To explore the
involvement of TLRs in ompAmutant-induced cell activation,
the function of the MyD88 adaptor molecule was interrupted
by siRNA. In MyD88 knocked down cells, 52OmpA2 induced
neither the activation of the NF-B reported construct nor the
secretion of IL-8 (Fig. 6, A and B, respectively). 52145-
wcaK2ompA still activated the NF-B reported construct and
induced the secretion of IL-8, although the levels were signifi-
cantly lower than those of infected cells transfected with con-
trol siRNA (Fig. 6,A andB). Similar results were obtainedwhen
cells were infected with 52145-wcaK2 (Fig. 6, A and B). To
further dissect the contribution of TLR-dependent signaling to
ompA mutant-induced cell activation, TLR2 and TLR4 were
knocked down by siRNA. Results shown in Fig. 6,C–F, indicate
that both receptors contributed to 52OmpA2- and 52145-
wcaK2ompA-induced cell activation. However, 52145-
wcaK2ompA still triggered the activation of NF-B and
induced the secretion of IL-8 inTLR knocked down cells (Fig. 6,
E and F, respectively). On the whole, these data suggest that
52OmpA2-induced NF-B activation and IL-8 secretion is
mediated by the TLR4-TLR2-MyD88 pathway and that 52145-
wcaK2ompA may also activate additional MyD88-indepen-
dent signaling pathway(s).
Another PRR constitutively expressed by airway epithelial
cells is NOD1 (51–54), and its engagement also results in the
activation of NF-B and MAPK signaling cascades (53). This
led us to explore whether NOD1 contributes to 52145-
wcaK2ompA-induced cell activation by using siRNA to knock
down its expression. As shown in Fig. 6, G and H, there was a
reduction in 52145-wcaK2ompA-triggered NF-B activation
and IL-8 secretion in NOD1 knockdown cells compared with
those found in control siRNA-treated cells. Similar results were
obtainedwhen cells were infectedwith 52145-wcaK2 (Fig. 6,G
and H). 52OmpA2-induced NF-B activation and IL-8 secre-
tion in NOD1 knockdown cells were similar to those found in
control siRNA-treated cells (Fig. 6, G and H). In contrast to
Kp52145 and 52OmpA2, 52145-wcaK2ompA and 52145-
wcaK2 did trigger NF-B-dependent reporter activity in
NOD1-expressing HEK293T cells (Fig. 6I). Altogether, these
data indicate that the other signaling pathway engaged by
52145-wcaK2ompA to activate NF-B and induce IL-8 secre-
tion is NOD1-dependent. The efficiency of siRNA-mediated
down-regulation of target gene mRNA levels was confirmed by
RT-qPCR (Fig. 6J).
Virulence of K. pneumoniae ompA Mutant—To determine
the ability of 52OmpA2 to cause pneumonia, C57BL/6JOlaHsd
mice were infected intranasally, and 24 and 96 h postinfection,
bacterial loads in trachea and lung homogenates were deter-
mined. At 24 h postinfection, Kp52145 and 52OmpA2 colo-
nized trachea and lungs, although bacterial loads of 52OmpA2
FIGURE 5. Activation of MAPKs is required for K. pneumoniae ompAmutant-induced IL-8 expression. A, immunoblots showing phospho-p38 (P-p38),
phospho-p44/42 (P-p44/42), phospho-JNK (P-JNK), and tubulin levels in cell extracts of A549 cells left uninfected (CON; time 0) or infected with K. pneumoniae
strains fordifferent times. The results are representativeof three independent experiments.B, ELISAof IL-8 releasedbyA549cells left untreated (CON;white bar)
or infected for 6 h with either 52OmpA2 (gray bars) or 52145-wcaK2ompA (black bars) in the absence or presence of different concentrations of SB203580 (2
and 4g/ml; p38MAPK inhibitor), U0126 (1 and 10g/ml; p44/42MAPK inhibitor), or SP600125 (5 and 10g/ml; JNKMAPK inhibitor), which were added 2 h
before infecting the cells and kept until the end of the experiment (n  3). The data (B) are means and S.E. (error bars). *, p  0.05 (results are significantly
different from the results for untreated cells; one-way ANOVA). , p 0.05 (results are significantly different from the results for infected cells in the absence
of inhibitor).
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were lower than those of the wild type (Fig. 7A). At 96 h postin-
fection, an increase of bacterial loadswas found in tracheas (Fig.
7, compare A and B) that were not significantly different
between both strains (Fig. 7B). In contrast, bacterial loads of
52OmpA2 in lungs were significantly lower than those of the
wild-type strain (Fig. 7B).
DISCUSSION
In this study, we provide new insights into the role of OmpA
as a virulence factor. Our findings revealed that K. pneumoniae
OmpAplays a role in the progression of the infection and that it
is important for immune evasion. Thus, we show that the
K. pneumoniae ompAmutant, strain 52OmpA2, induces higher
levels of inflammatory mediators than the wild-type strain in
vitro and in vivo. Mechanistically, we present evidence showing
that 52OmpA2 activates NF-B-dependent and MAPK p38-
and p44/42-dependent signaling pathways. In addition, ompA
mutant induction of inflammatory responses is dependent on
TLR2-TLR4-MyD88 activation. Finally, we demonstrate that
the ompA mutant is attenuated in the pneumonia mouse
model.
Innate immune responses, particularly inflammation, are
essential for effective lung defense against pathogens. To acti-
vate these responses, the host recognizes conserved molecules
uniquely expressed by pathogens, the so-called PAMPs, which
are characterized by being expressed among entire classes of
pathogens, are important for the survival/virulence of the
pathogen, and are distinguishable from “self.” These PAMPs
are also targeted by weapons of the innate systemwith antibac-
terial properties, such as antimicrobial peptides and the com-
plement system. In turn, many PAMPs play an important role
in immune evasion by the pathogen. Our findings, together
with others, give support to the notion that K. pneumoniae
OmpA should be considered a bona fide PAMP. OmpA is tar-
geted by neutrophil elastase and serum amyloid protein A,
hence leading to cell death and increased bacterial phagocyto-
sis, respectively (7–9). However, OmpA protects bacteria
against the bactericidal action of lung collectins and antimicro-
bial peptides (6, 39), and here we have shown that it acts as
immune evasin. On the whole, this evidence points out that an
essential attribute of K. pneumoniae OmpA is to thwart the
innate immune system.
Other studies have shown that recombinant purified
K. pneumoniaeOmpA induces the expression of proinflamma-
tory molecules in various cell types, including airway epithelial
cells (for a review, see Ref. 36). Hence, it has been postulated
that recognition of OmpA contributes to the activation of host
responses leading to the clearance of K. pneumoniae (36).
Given that in this work we used a bacterial mutant instead of a
recombinant protein, our data, far from challenging these find-
ings, shed new light on OmpA functions in its physiological
context, the OM. In fact, we emphasize that care should be
taken to extrapolate findings obtained using purified products
to the outcome of an infection process and that usingwhole live
bacteria is a more likely in vivo scenario. It should be noted that
the ompAmutant strain was shown to induce more inflamma-
tion in vivo and in vitro than the wild-type strain. Interestingly,
and in agreement with our findings, E. coli ompAmutant strain
induces higher expression of proinflammatory mediators than
the wild type in vitro (55).
Recently, we have demonstrated that K. pneumoniae coun-
teracts the activation of inflammatory responses by inducing
the deubiquitinase CYLD and the phosphatase MKP-1
(DUSP1) in a NOD1-dependent manner (45). This action was
strictly dependent on bacteria-cell contact (45). Furthermore,
bacterial removal by gentamicin treatment rendered cells again
responsive to proinflammatory mediators (45). Considering
that CPS was necessary but not sufficient to attenuate inflam-
mation (45), in this work we asked whether OmpA couldmedi-
ate this attenuation. However, findings shown in Fig. 2 do not
support this. These results do not contradict the other findings
reported in this work showing that 52OmpA2 does activate
inflammatory responses. It should be noted that in most exper-
iments of this study, gentamicin is used to remove bacteria after
2 h of infection, and, for example, IL-8 in the supernatants is
measured at 4 or 6 h postinfection. In turn, the fact that
52OmpA2-induced responses were dependent on TLR2-
TLR4-MyD88 activation suggests that OmpA, together with
CPS, perturbs TLR-dependent recognition of K. pneumoniae.
FIGURE 6. Role ofMyD88, TLR2, TLR4, and NOD1 in K. pneumoniae ompAmutant-induced cell activation. A, C, E, and G, activation of an NF-B luciferase
reporter plasmid in A549 cells transfected with either control or the indicated siRNA for different pattern recognition receptors, which were left untreated
(white bars) or infected for 8hwithdifferent strains. Activity is normalizedbycorrectionofRenillaexpressionand ispresented relative to the cells untreated (n
3). B, D, F, and H, ELISA of IL-8 released by A549 cells transfected with either control or the indicated siRNA for different pattern recognition receptors, which
were left untreated (white bars) or infected for 8 hwith different strains (n 3). I, activation of anNF-B luciferase reporter plasmid inHEK293T cells transfected
with HA-NOD1 plasmid, which were left untreated (white bar) or infected with the indicated strains for 8 h. Activity is normalized by correction of Renilla
expressionand is presented relative tountreated cells (data aremeans andS.E. (error bars);n3). J, siRNAefficiencywasquantifiedbyRT-qPCR in samples from
the same experiment shown in A–H. mRNA level was normalized to GADPH, and then relative mRNA levels in cells transfected with control siRNA or specific
siRNAwere compared.mRNA levels in cells transfectedwith control siRNAwere set to 100% (data aremeans and S.E.; n 3).Gray bars, CPS-expressing strains;
black bars, CPS-negative strains.A–H,, p 0.05 (results are significantly different from the results for untreated cells; one-way ANOVA); *, p 0.05 (results are
significantly different from those for transfected cells with control siRNA infectedwith the same strain). I, *, p 0.05 (results are significantly different from the
results for untreated cells; one-way ANOVA).
FIGURE 7. Bacterial counts in mouse organs at 24 h postinfection (A) or
96 h postinfection (B).Mice were infected intranasally with a bacterial mix-
ture containing 5 104 bacteria of wild type (Kp52145) (F) or ompAmutant
(52OmpA2) (E). Results were reported as log cfu/g of tissue. *, results are
significantlydifferent (p0.05; one-tailed t test) fromthe results for Kp52145.
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On the whole, this evidence is consistent with amodel in which
the reduced inflammatory response characteristic of K. pneu-
moniae infections is the sum of prevention of TLR-dependent
recognition of Klebsiella (mediated at least by CPS and OmpA)
and the anti-inflammatory effect (K. pneumoniae effectors yet
to be identified) recently described (45).
Our findings further sustain the notion that airway epithelial
cells orchestrate a defense response upon pathogen challenge
by activating NF-B- and MAPK-dependent signaling path-
ways (56). In fact, activation of these pathways seems to be a
central event of pathogen-exposed epithelial cells lining muco-
sal surfaces. Interestingly, this is true regardless of the tissue
local environment, either constantly exposed to microbes, like
the intestinal tract, or essentially sterile, like the urinary and
respiratory tracts. Although p38 and p44/42 MAPKs were
required for ompA mutant strain-induced IL-8, the mutants
also activated JNK MAPK, hence suggesting that there may be
additional host cell responses activated in a JNKMAPK-depen-
dent manner. Future studies will aim to identify these
responses.
The ompAmutant strains tested in this study engaged differ-
ent PRRs, depending on the expression ofCPSon their surfaces.
Strain 52OmpA2, expressing CPS, engaged TLR2 and TLR4,
whereas strain 52145-wcaK2ompA, lackingCPS, activated not
only TLR2 and TLR4 but also NOD1. These and our previous
findings implicating TLR2 and TLR4 in the recognition of a
K. pneumoniae CPS mutant (22, 32) suggest that TLR-medi-
ated recognition of K. pneumoniae is a key event for the induc-
tion of host defense responses against this pathogen. Support-
ing this, MyD88- and TLR4-dependent responses are essential
for successful mouse defense against K. pneumoniae pneumo-
nia (29, 30). Our results implicate NOD1 in the recognition of
K. pneumoniaeCPSmutants, strains 52145-wcaK2ompA (this
work) and 52145-wcaK2 (this work and Ref. 22). Taking into
account that K. pneumoniae CPS mutants are internalized by
epithelial cells (43, 44), a NOD1-dependent recognition is con-
sistent with the idea that this PRR participates in the recogni-
tion of internalized pathogens (53, 57, 58). Intracellular 52145-
wcaK2ompA and 52145-wcaK2 reside in vacuoles displaying
features of acidic late endosomes,4 thereby raising the question
of how bacteria that do not reach the cytosol could activate
NOD1. However, recent studies indicate that there is a link
between endosomal acidification/maturation and NOD-de-
pendent responses (59–61). Furthermore, data indicate that
bacterial products are actively transported from the phagosome
to the cytosol to engage NOD receptors (59–61).
Here, we demonstrate for the first time, using a pneumonia
mouse model, that OmpA is important for bacterial survival in
the lung. Research over the last 20 years has demonstrated a
correlation between activation of inflammatory responses and
Klebsiella clearance from the airways (26–28). Hence, the
higher inflammatory response induced by 52OmpA2may con-
tribute to the mutant’s clearance. The in vivo scenario is com-
plex, and the final outcome of pneumonia is the combination of
the action of antimicrobial factors (among others complement
and antimicrobial peptides) and several types of cells, including
alveolar macrophages, epithelial cells, and neutrophils. It
should be noted that cytokines and chemokines released by
epithelial cells do increase the bactericidal activity of profes-
sional phagocytes. Studies are ongoing to determine whether
OmpA plays any role in the interaction of K. pneumoniae with
alveolar macrophages and neutrophils.
Finally, it is worthwhile commenting on the clinical implica-
tions of our findings. We put forward the idea that compounds
directed to block OmpA may be new promising therapeutic
molecules to treat infections caused byGram-negative bacteria,
at least those caused by Klebsiella. Data from our laboratory
suggest that these compounds will render bacteria susceptible
to the bactericidal elements of the innate immune system (39)
and will also increase TLR-mediated defense responses (this
work). Both actions should facilitate the clearance of the patho-
gen from the airways, which might be further enhanced with
the aid of antibiotics.
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